Based on the dataset provided, the total number of scientific publications in drug discovery in Brazil showed fluctuations between 2013 and 2023, with the total standing at 226.9 units in 2023. Year-on-year variations reflect a highly dynamic environment: a decrease of 8.49% in 2013, followed by several years of minor changes until 2018, which saw a 10.93% increase. In recent years under review, the variation stabilized somewhat, showing an increase of 1.49% in 2023. The Compound Annual Growth Rate (CAGR) over the five-year periods indicates moderate growth, with a timeline fluctuation. The forecasted data suggest continued incremental growth, with a forecasted 5-year CAGR of 0.97% and a 5-year growth rate of 4.97% by 2028.
Future trends to watch for include the potential impact of policy changes in Brazil, advancements in AI and machine learning in drug discovery, and increased international collaboration. These factors could significantly alter the growth trajectory of scientific publications in the sector.
